Skip to content
  • Sunday, 26 July 2026
  • 3:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Screwworm, Shingles Vaccine’s Anti-Aging Potential, and Critical Public Health Data.
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Explores Screwworm, Shingles Vaccine’s Anti-Aging Potential, and Critical Public Health Data.

Lina Irawan Apr 23, 2026 0

In a recent episode of "This Week in Virology" (TWiV), Dr. Daniel Griffin provided his weekly clinical update, delving into…

Read More
Microbiology & Immunology

TWiV 1290: Clinical Update with Dr. Daniel Griffin Discusses Screwworm, Shingles Vaccine’s Anti-Aging Effects, and Current Public Health Data

Lina Irawan Mar 25, 2026 0

In a recent clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive…

Read More
Breakthrough Study Reveals Synergistic Drug Combination to Overcome Differentiation Blockade in Acute Myelogenous LeukemiaLiving Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionBaylor College of Medicine Researchers Identify Sox9 Protein as Key to Clearing Amyloid Plaques and Preserving Memory in Alzheimer’s ModelsScience News: A Century of Empowering Public Understanding of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ